BioLife Solutions (NASDAQ:BLFS – Get Free Report) and Generation Alpha (OTCMKTS:GNAL – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership.
Institutional & Insider Ownership
93.2% of BioLife Solutions shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by insiders. Comparatively, 60.8% of Generation Alpha shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Earnings & Valuation
This table compares BioLife Solutions and Generation Alpha”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BioLife Solutions | $82.25 million | 14.49 | -$20.18 million | ($0.07) | -353.71 |
| Generation Alpha | N/A | N/A | N/A | N/A | N/A |
Generation Alpha has lower revenue, but higher earnings than BioLife Solutions.
Risk and Volatility
BioLife Solutions has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500. Comparatively, Generation Alpha has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.
Profitability
This table compares BioLife Solutions and Generation Alpha’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BioLife Solutions | -3.20% | 0.97% | 0.87% |
| Generation Alpha | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of recent recommendations and price targets for BioLife Solutions and Generation Alpha, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioLife Solutions | 1 | 1 | 3 | 0 | 2.40 |
| Generation Alpha | 0 | 0 | 0 | 0 | 0.00 |
BioLife Solutions presently has a consensus target price of $32.00, suggesting a potential upside of 29.24%. Given BioLife Solutions’ stronger consensus rating and higher possible upside, equities research analysts clearly believe BioLife Solutions is more favorable than Generation Alpha.
Summary
BioLife Solutions beats Generation Alpha on 8 of the 10 factors compared between the two stocks.
About BioLife Solutions
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
About Generation Alpha
Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting, plant nutrient products, and ancillary equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lighting controller, a temperature monitoring control system; reflectors; and high intensity lighting accessories, as well as plant nutrients and fertilizers. It primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is based in Upland, California.
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
